Originally published In Press as doi:10.1074/mcp.M700029-MCP200 on May 28, 2007.
Molecular & Cellular Proteomics 6:1589-1598, 2007.
© 2007 by The American Society for Biochemistry and Molecular Biology, Inc.
Research
The Implications of Proteolytic Background for Shotgun Proteomics*,S
Paola Picotti ,
Ruedi Aebersold , ,¶ and
Bruno Domon ,||
From the Institute of Molecular Systems Biology, ETH Zürich, CH-8093 Zürich, Switzerland, Faculty of Sciences, University of Zürich, CH-8006 Zürich, Switzerland, and ¶ Institute for Molecular Systems Biology, Seattle, Washington 98103
The analysis by liquid chromatography coupled to tandem mass spectrometry of complex peptide mixtures, generated by proteolysis of protein samples, is the main proteomics method used today. The approach is based on the assumption that each protein present in a sample reproducibly and predictably generates a relatively small number of peptides that can be identified by mass spectrometry. In this study this assumption was examined by a targeted peptide sequencing strategy using inclusion lists to trigger peptide fragmentation attempts. It was found that the number of peptides observed from a single protein is at least one order of magnitude greater than previously assumed. This unexpected complexity of proteomics samples implies substantial technical challenges, explains some perplexing results in the proteomics literature, and prompts the need for developing alternative experimental strategies for the rapid and comprehensive analysis of proteomes.
|| To whom correspondence should be addressed: Inst. of Molecular Systems Biology, ETH Zürich, Wolfgang-Pauli-Str. 16, HPT D 74, 8093 Zürich, Switzerland. Tel.: 41-44-633-20-88; E-mail: domon{at}imsb.biol.ethz.ch

CiteULike Complore Connotea Del.icio.us Digg Reddit Technorati What's this?
This article has been cited by other articles:

|
 |

|
 |
 
J. D. Jaffe, H. Keshishian, B. Chang, T. A. Addona, M. A. Gillette, and S. A. Carr
Accurate Inclusion Mass Screening: A Bridge from Unbiased Discovery to Targeted Assay Development for Biomarker Verification
Mol. Cell. Proteomics,
October 1, 2008;
7(10):
1952 - 1962.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
U. Kruse, M. Bantscheff, G. Drewes, and C. Hopf
Chemical and Pathway Proteomics: Powerful Tools for Oncology Drug Discovery and Personalized Health Care
Mol. Cell. Proteomics,
October 1, 2008;
7(10):
1887 - 1901.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. A. Galan, M. Guo, E. E. Sanchez, E. Cantu, A. Rodriguez-Acosta, J. C. Perez, and W. A. Tao
Quantitative Analysis of Snake Venoms Using Soluble Polymer-based Isotope Labeling
Mol. Cell. Proteomics,
April 1, 2008;
7(4):
785 - 799.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
P. J. Ulintz, B. Bodenmiller, P. C. Andrews, R. Aebersold, and A. I. Nesvizhskii
Investigating MS2/MS3 Matching Statistics: A Model For Coupling Consecutive Stage Mass Spectrometry Data For Increased Peptide Identification Confidence
Mol. Cell. Proteomics,
January 1, 2008;
7(1):
71 - 87.
[Abstract]
[Full Text]
[PDF]
|
 |
|
Copyright © 2007 by the American Society for Biochemistry and Molecular Biology.
|
Advertisement
Advertisement
|